These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6303021)

  • 1. [Toxicity of Bordetella pertussis suspensions associated with the preparation of pertussis vaccine].
    Raĭkher LI; Kalinina ES; Shafran MI; Khazina EKh; Aĭnbinder ZTs
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):15-7. PubMed ID: 6303021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative characteristics of the toxic properties of the whooping cough microbes].
    Chuprinina RP
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Sep; 0(9):111-6. PubMed ID: 173120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative pathomorphologic study of the toxic properties of a corpuscular pertussis vaccine and of a cell-free pertussis preparation].
    Grigor'eva LV; Ozeretskovskaia MN; Chigirinskiĭ AE; Koval'skaia SIa; Bazhanova IG
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Aug; (8):52-7. PubMed ID: 2555983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity testing of pertussis vaccines: effect of increased sensitivity of mice to Bordetella pertussis.
    Cameron J; Desormeaux Y; De Bellefeuille ML; Leclerc J
    J Biol Stand; 1984 Jan; 12(1):19-24. PubMed ID: 6321509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic and reactogenic properties of pertussis bacteria (experimental and clinical studies).
    Demina AA; Semina NA; Trofimova NP; Igonina YA; Gracheva AM
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(3):293-304. PubMed ID: 171306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunogenicity and toxicity of soluble trichloroacetic acid precipitate from pertussis microbes and its fractions].
    Bazhanova IG; Gladkaia VI; Liashenko VA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Nov; (11):128-32. PubMed ID: 202117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing the stability of acid-precipitated polyvalent Bordetella pertussis bulk suspensions.
    Csizér Z; Zsidai J; Joó I
    Acta Microbiol Acad Sci Hung; 1975; 22(2):83-93. PubMed ID: 164759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The development of a new generation of pertussis vaccine].
    Chuprinina RP; Bychenko BD; Smirnov VD; Maksiutov RV; Eglit IuKh
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Oct; (10):89-94. PubMed ID: 2075771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mitogenic action of the liquid phase of a microbial suspension of Bordetella pertussis].
    Amelina IP; Pronin AV; Lapaeva IA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jul; (7):6-10. PubMed ID: 2890249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detoxification of Bordetella pertussis organisms or pertussis toxin with glutaraldehyde for preparation of pertussis vaccine.
    Gupta RK
    Vaccine; 1991 Sep; 9(9):690-1. PubMed ID: 1950101
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of purified components of Bordetella pertussis in the weight gain test for the toxicity testing of pertussis vaccines.
    Redhead K; Seagroatt V
    J Biol Stand; 1986 Jan; 14(1):57-65. PubMed ID: 2870067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity and potency evaluation of pertussis vaccines.
    Corbel MJ; Xing DK
    Expert Rev Vaccines; 2004 Feb; 3(1):89-101. PubMed ID: 14761246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in Bordetella pertussis.
    Cameron J
    J Pathol Bacteriol; 1967 Oct; 94(2):367-74. PubMed ID: 4294462
    [No Abstract]   [Full Text] [Related]  

  • 14. [A comparative analysis of the effect of Bordetella pertussis preparations on a primary culture of murine peritoneal macrophages].
    Tiukavkina SIu; Moskalenko EP
    Mikrobiol Z; 1996; 58(2):58-63. PubMed ID: 8983523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of formaldehyde on the toxicity and potency of pertussis vaccine.
    Gottshall RY; Nelson E; Angela F; Anderson G
    Health Lab Sci; 1975 Jan; 12(1):35-40. PubMed ID: 1053237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interrelation of the toxicity and capacity of pertussis vaccines to alter the body immune response to heterogenetic antigens].
    Levina LA; Elkina SI; Beĭlina VB; Prilepin NA; Kalina NG
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Jan; (1):75-9. PubMed ID: 6282013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detoxification of Bordetella pertussis with glutaraldehyde.
    Iida T; Horiuchi Y
    J Biol Stand; 1987 Jan; 15(1):17-26. PubMed ID: 2881932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis antigens--screening models on toxicity.
    Ronneberger H; Blackkolb F; Guthöhrlein G
    Arch Toxicol Suppl; 1982; 5():129-32. PubMed ID: 6285854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation from Bordetella pertussis of protective antigen free from toxic activity and histamine sensitizing factor.
    Nagel J
    Nature; 1967 Apr; 214(5083):96-7. PubMed ID: 4291816
    [No Abstract]   [Full Text] [Related]  

  • 20. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin.
    Hegerle N; Paris AS; Brun D; Dore G; Njamkepo E; Guillot S; Guiso N
    Clin Microbiol Infect; 2012 Sep; 18(9):E340-6. PubMed ID: 22717007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.